STOCK TITAN

Aramark US SEC Filings

ARMK NYSE

Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.

Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.

Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.

The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.

Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.

Filing
Rhea-AI Summary

Aramark’s Chief Executive Officer reports a routine share withholding for taxes. On 12/02/2025, the CEO, who is also a director, had 5,467.695 shares of Aramark common stock withheld at a price of $37.08 per share. The filing explains that these shares were withheld to cover taxes due on the vesting of restricted stock units, rather than being an open‑market sale. Following this tax-related transaction, the CEO beneficially owned 1,017,262.358 shares of Aramark common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark filed a Form 4 reporting a routine equity transaction by its COO, U.S. Food & Facilities. On 12/02/2025, 1,116.373 shares of Aramark common stock were withheld at a price of $37.08 per share to cover taxes due on the vesting of restricted stock units. After this tax withholding, the executive beneficially owns 296,626.298 shares of Aramark common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark's Executive Vice President and Chief Financial Officer reported a routine equity transaction involving company stock. On 12/02/2025, the officer had 930.8 shares of common stock withheld at a price of $37.08 per share to cover taxes due on the vesting of restricted stock units. After this tax withholding, the officer beneficially owned 61,260.478 shares of Aramark common stock in direct ownership. This type of transaction does not represent an open-market buy or sell, but an administrative step related to equity compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Aramark reported that its EVP & Chief HR Officer acquired additional equity on 12/01/2025. The executive received 9,440 restricted stock units of common stock at a reference price of $37.08 per share, increasing total beneficial ownership of common stock to 81,850.61 shares.

The same day, the executive was granted 33,708 stock options with an exercise price of $37.08 per share, exercisable for 33,708 shares of common stock and expiring on 12/01/2035. Both the restricted stock units and the options vest in four equal annual installments beginning on the first anniversary of the grant date, tying value to multi‑year service and performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark reported an equity grant to one of its senior executives. On 12/01/2025, the SVP, Controller and CAO acquired 4,315 shares of common stock at a price of $37.08, increasing directly held common stock to 40,604.957 shares after the transaction. The filing also shows a grant of stock options covering 7,705 shares of common stock with an exercise price of $37.08 per share, expiring on 12/01/2035.

The 4,315 shares are in the form of restricted stock units that vest in four equal annual installments starting on the first anniversary of the grant date. The 7,705 stock options vest on the same four-year schedule, also in equal annual installments beginning one year after the grant. These awards are a form of long-term incentive compensation that ties the executive’s potential future value to Aramark’s share price over time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark executive vice president and CFO reported new equity awards in the company’s stock. On 12/01/2025, the officer acquired 9,440 shares of common stock as restricted stock units at a reference price of $37.08 per share, bringing direct beneficial ownership to 62,191.278 shares. These restricted stock units vest in four equal annual installments starting on the first anniversary of the grant date.

The officer also received a stock option award giving the right to buy 33,708 shares of common stock at an exercise price of $37.08 per share, expiring on 12/01/2035. The options vest in four equal annual installments beginning on the first anniversary of the grant date, tying the executive’s compensation more closely to Aramark’s long-term share performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Aramark reported an equity award to its Chief Executive Officer and director on 12/01/2025. The CEO acquired 51,241 shares of common stock at a reference price of $37.08, increasing his directly held stake to 1,022,730.053 shares.

He also received stock options for 182,983 shares with a $37.08 exercise price, expiring on 12/01/2035. Both the restricted stock units and these options vest in four equal annual installments starting on the first anniversary of the grant date, tying a portion of his compensation to Aramark’s long-term share performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark’s COO of U.S. Food & Facilities reported new equity awards and updated holdings. On 12/01/2025, the executive acquired 11,597 restricted stock units of Aramark common stock at a reference price of $37.08 per share, bringing directly held common stock to 297,742.671 shares after the transaction.

The filing also shows a grant of 41,412 stock options with an exercise price of $37.08 per share, expiring on 12/01/2035. Both the restricted stock units and the options vest in four equal annual installments beginning on the first anniversary of the grant date, tying the executive’s compensation to longer-term company performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Aramark’s Executive Vice President and General Counsel reported new equity awards in the form of common stock and stock options. On 12/01/2025, the insider acquired 9,440 shares of common stock, described as restricted stock units that vest in four equal annual installments beginning on the first anniversary of the grant date, at a listed price of $37.08 per share. After this transaction, the insider beneficially owned 127,540.787 shares of Aramark common stock directly.

The filing also shows a grant of 33,708 stock options with an exercise price of $37.08 per share, which vest in four equal annual installments starting on the first anniversary of the grant date and expire on 12/01/2035. Following this grant, the insider directly held 33,708 stock options linked to Aramark common stock. The report is filed as a Form 4 by one reporting person and reflects routine equity-based compensation for a senior executive.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Aramark executive files Form 4 reporting tax-related share withholding. On 11/27/2025, the company’s EVP and General Counsel reported the disposition of 1,433.398 shares of Aramark common stock at $37.3 per share. The filing states these shares were withheld to cover taxes due upon the vesting of restricted stock units. After this transaction, the reporting person beneficially owned 118,100.787 shares of Aramark common stock directly. This is an administrative equity and tax event rather than an open-market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
insider

FAQ

How many Aramark US (ARMK) SEC filings are available on StockTitan?

StockTitan tracks 117 SEC filings for Aramark US (ARMK), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Aramark US (ARMK)?

The most recent SEC filing for Aramark US (ARMK) was filed on December 4, 2025.